Skip to main content

Advertisement

SpringerLink
Log in

Retinoblastoma Cell Culturing and Evaluation of Their Drug Resistance

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We obtained primary culture of retinoblastoma cells and evaluated the resistance of cultured ells to chemotherapy. The study included 19 patients aged 6-64 months (mean 27.9±17.4 months); of these, 6 (31.6%) patients with bilateral retinoblastoma and 13 (68.4%) patients with unilateral form. In 18 (94.7%) patients, group E retinoblastoma was diagnosed. Enucleation was performed in all patients; in 94.7% cases, low-differentiated retinoblastoma was identified. Samples of the tumor tissue were taken to derive a cell culture and to study drug resistance and metabolic activity of cells (MTT test). In 4 cases, adhesion primary cultures of retinoblastoma were derived. Cytological verification of the obtained cultures was performed. The primary cultures were derived from 4 of 6 bilateral tumors and from none of 13 unilateral tumors (p=0.003). There were no statistically significant correlations with patient age (p=0.33) and the presence of calcifications in the tumor (p=0.26). MTT test revealed no differences in the sensitivity of cell cultures to irinotecan and ifosfamide. Pronounced differences in the resistance of cell cultures were observed for oxaliplatin and ascorbic acid. MTT test with evaluation of drug resistance can be used both in clinical practice for adjusting chemotherapy regimen and in development of new approaches to the treatment of retinoblastoma with assessment of in vivo tumor cell resistance in animal models.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gerasimova GK, Sidorova TA, Khorosheva EV, Shtil’ AA. The efficiency of the teraftal+ascorbic acid catalytic system against tumor cells with the multidrug resistance phenotype. Ross. Bioter. Zh. 2009;8(3):20. Russian.

    Google Scholar 

  2. Saakyan SV, Tsygankov АYu, Ivanova ОА, Zakharova GP, Isaeva RТ, Moiseeva NI, Karamysheva АF. Malignant medulloepithelioma mimicking retinoblastoma - clinical and morphological case analysis and cell culture experience. Vestn. Oftal’mol. 2016;132(6):64-69. Russian.

    Article  CAS  Google Scholar 

  3. Antoneli CB, Ribeiro KB, Rodriguez-Galindo C, Soares FA, Arias VA, Novaes PE, Chojniak MM, Malogolowkin M. The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement. J. Pediatr. Hematol. Oncol. 2007;29(10):700-704.

    Article  PubMed  CAS  Google Scholar 

  4. Antoneli CB, Steinhorst F, de Cássia Braga Ribeiro K, Novaes PE, Chojniak MM, Arias V, de Camargo B. Extraocular retinoblastoma: a 13-year experience. Cancer. 2003;98(6):1292-1298.

    Article  PubMed  Google Scholar 

  5. Busch M, Philippeit C, Weise A, Dünker N. Re-characterization of established human retinoblastoma cell lines. Histochem. Cell. Biol. 2015;143(3):325-338.

    Article  PubMed  CAS  Google Scholar 

  6. Chévez-Barrios P, Hurwitz MY, Louie K, Marcus KT, Holcombe VN, Schafer P, Aguilar-Cordova CE, Hurwitz RL. Metastatic and nonmetastatic models of retinoblastoma. Am. J. Pathol. 2000;157(4):1405-1412.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Cozza R, De Ioris M.A, Ilari I, Devito R, Fidani P, De Sio L, Demelas F, Romanzo A, Donfrancesco A. Metastatic retinoblastoma: single institution experience over two decades. Br. J. Ophthalmol. 2009;93(9):1163-1166.

    Article  PubMed  CAS  Google Scholar 

  8. Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, Gallie BL. Retinoblastoma. Lancet. 2012;379:1436-1446.

    Article  PubMed  Google Scholar 

  9. Eagle RC Jr. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch. Pathol. Lab. Med. 2009;133(8):1203-1209.

    PubMed  Google Scholar 

  10. Fazili N, Balagholi S, Amizadeh Y, Hosseini SB, Kanavi MR. Cultivation of retinoblastoma cells: correlation between in vitro growth pattern and histopathology. J. Ophthalmic Vis. Res. 2016;11(4):379-384.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Griegel S, Hong C, Frötschl R, Hülser DF, Greger V, Horsthemke B, Rajewsky MF. Newly established human retinoblastoma cell lines exhibit an “immortalized” but not an invasive phenotype in vitro. Int. J. Cancer. 1990;46(1):125-132.

    Article  PubMed  CAS  Google Scholar 

  12. Kaliki S, Shields CL. Retinoblastoma: achieving new standards with methods of chemotherapy. Indian J. Ophthalmol. 2015;63(2):103-109.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kim JH, Kim JH, Yu YS, Kim DH, Kim CJ, Kim KW. Establishment and characterization of a novel, spontaneously immortalized retinoblastoma cell line with adherent growth. Int. J. Oncol. 2007;31(3):585-592.

    PubMed  CAS  Google Scholar 

  14. Laurie N, Mohan A, McEvoy J, Reed D, Zhang J, Schweers B, Ajioka I, Valentine V, Johnson D, Ellison D, Dyer MA. Changes in retinoblastoma cell adhesion associated with optic nerve invasion. Mol. Cell. Biol. 2009;29(23):6268-62282.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Lauricella M, Giuliano M, Emanuele S, Vento R, Tesoriere G. Apoptotic effects of different drugs on cultured retinoblastoma Y79 cells. Tumour Biol. 1998;19(5):356-363.

    Article  PubMed  CAS  Google Scholar 

  16. Lee EY, Bookstein R, Young LJ, Lin CJ, Rosenfeld MG, Lee WH. Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79. Proc. Natl Acad. Sci. USA. 1988;85(16):6017-6021.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Liu Q, Wang Y, Wang H, Liu Y, Liu T, Kunda PE. Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis. J. Cancer Res. Clin. Oncol. 2013;139(8):1357-1372.

    Article  PubMed  CAS  Google Scholar 

  18. Madhavan J, Ganesh A, Roy J, Biswas J, Kumaramanickavel G. The relationship between tumor cell differentiation and age at diagnosis in retinoblastoma. J. Pediatr. Ophthalmol. Strabismus. 2008;45(1):22-25.

    Article  PubMed  Google Scholar 

  19. Madreperla SA, Bookstein R, Jones OW, Lee WH. Retinoblastoma cell lines Y79, RB355 and WERI-Rb27 are genetically related. Ophthalmic Paediatr. Genet. 1991;12(1):49-56.

    Article  PubMed  CAS  Google Scholar 

  20. McFall RC, Sery TW, Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res. 1977;37(4):1003-1010.

    PubMed  CAS  Google Scholar 

  21. Medina MA, García de Veas R, Schweigerer L. Ascorbic acid is cytotoxic for pediatric tumor cells cultured in vitro. Biochem. Mol. Biol. Int. 1994;34(5):871-874.

    PubMed  CAS  Google Scholar 

  22. Pichi F, Lembo A, De Luca M, Hadjistilianou T, Nucci P. Bilateral retinoblastoma: clinical presentation, management and treatment. Int. Ophthalmol. 2013;33(5):589-593.

    Article  PubMed  Google Scholar 

  23. Roomi MW, Roomi N, Bhanap B, Niedzwiecki A, Rath M. Antineoplastic activity of a nutrient mixture in Y-79 malignant retinoblastoma cells. Oncol. Rep. 2013;29(1):29-33.

    Article  PubMed  Google Scholar 

  24. Ruggiero A, Trombatore G, Triarico S, Arena R, Ferrara P, Scalzone M, Pierri F, Riccardi R. Platinum compounds in children with cancer: toxicity and clinical management. Anticancer Drugs. 2013;24(10):1007-1019.

    Article  PubMed  CAS  Google Scholar 

  25. Schouten-van Meeteren AY, van der Valk P, van der Linden HC, Moll AC, Imhof SM, Huismans DR, Loonen AH, Veerman AJ. Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay. Cancer. 2001;92(11):2933-2940.

    Article  PubMed  CAS  Google Scholar 

  26. Wang C, Lv H, Yang W, Li T, Fang T, Lv G, Han Q, Dong L, Jiang T, Jiang B, Yang G, Wang H. SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts. Cancer Lett. 2017;398:1-11.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Helmholtz Moscow Research Institute of Eye Diseases, Ministry of Health of the Russian Federation, Moscow, Russia

    S. V. Saakyan, А. Yu. Tsygankov, M. G. Zhil’tsova & S. S. Tadevosyan

  2. N. N. Blokhin National Medical Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

    N. I. Moiseeva & А. F. Karamysheva

Authors
  1. S. V. Saakyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. А. Yu. Tsygankov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. I. Moiseeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. А. F. Karamysheva
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. G. Zhil’tsova
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. S. Tadevosyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to А. Yu. Tsygankov.

Additional information

Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 1, pp. 38-44, January, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saakyan, S.V., Tsygankov, А.Y., Moiseeva, N.I. et al. Retinoblastoma Cell Culturing and Evaluation of Their Drug Resistance. Bull Exp Biol Med 165, 148–153 (2018). https://doi.org/10.1007/s10517-018-4117-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-4117-7

Key Words

Search

Navigation